Therapeutic compositions for treatment of human immunodeficiency virus
Grant
US12594244B2
Kind: B2
Apr 07, 2026
Assignee
Gilead Sciences, Inc.
Inventors
Benjamin Micah Collman, Lei Hong, Joanna M. Koziara
Abstract
A solid oral dosage form is provided, comprising a compound of Formula I or a pharmaceutically acceptable salt thereof, tenofovir alafenamide or a pharmaceutically acceptable salt thereof, and emtricitabine or a pharmaceutically acceptable salt thereof.
CPC Classifications
A61K 9/209
A61K 9/0053
A61K 9/2013
A61K 9/2027
A61K 9/2054
A61K 9/2086
A61K 9/2095
A61K 9/28
A61K 9/2833
A61K 31/513
A61K 31/5365
A61K 31/537
A61K 31/553
A61K 31/675
A61P 31/18
Filing Date
2025-09-29
Application No.
19343371
Claims
29